Boehringer Appoints Neumann To Board

Boehringer Ingelheim has named Dr. Andreas Neumann a member of its board of managing directors – effective October 1, 2015. He will assume responsibility for the corporate board division human resources. A fully qualified lawyer, Neumann joined the company in 2011 and has previously managed the corporate division legal. Since early 2015 he has also been in charge of the human resources business area.

Boehringer Ingelheim has named Dr. Andreas Neumann a member of its board of managing directors – effective October 1, 2015. He will assume responsibility for the corporate board division human resources. A fully qualified lawyer, Neumann joined the company in 2011 and has previously managed the corporate division legal. Since early 2015 he has also been in charge of the human resources business area.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Scrip

Asia Deal Watch: SunRock, Escugen Collaborate On CCR9-Targeted ADC

 

Axcelead/Lotte Biologics/Kanaph and NextCure/Simcere also unveil ADC-focused pacts, plus deals involving Avata/Oceanus, GSK/Bharat Biotech, Cullinan/Genrix and more.

J&J’s Trispecific Antibody For Myeloma Offers Improved Safety, Potency Over Bispecifics

 

The drugmaker presented data from its Phase I study of JNJ-79635322 at ASCO and EHA showing a 100% response rate in BCMA- and GPRC5D-naïve patients.

Defying Gravity: Five Drugs That Surpassed Their Sales Forecasts

 

Many assets outperform their pre-launch sales predictions despite the frequent overestimation of forecasts within the industry. In this article, Scrip highlights several such assets and the factors that influenced their predictions.